美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

生物科技

59.57

+1.061.82%

漲家數：404

跌家數：127

平家數：9

市盈率：- -

高：59.63

開：58.50

低：58.50

收：58.50

成交量：9.59億

成交額：156.45億

市值：1.55萬億

流通市值：1.39萬億

資料載入中...

BSC Meme幣BTSR市值突破1800萬美元，日內漲超48%

百濟神州(06160)授出合共約3.44億股美國存托股份的受限制股份單位

ALT5 Sigma盤前上漲5.7%，暫報7.34美元

港股生物醫藥股延續強勢！榮昌生物漲超16%創近4年新高，晶泰控股漲超15%

老虎资讯综合

港股異動 | 百濟神州(06160)漲超4% 皮下替雷利珠單抗啓動國內首個Ⅲ期臨牀

學者建議調整房產投資負扣税應用聯邦政府表示暫無改變負扣税計劃

澳洲财经见闻

180 Life Sciences Corp.8月13日成交額為12.18億美元

工會重磅提案：澳洲應推行四天工作制，應對“過勞危機”與工資停滯

澳洲财经见闻

美國命令 Vaxart 在 mRNA 終止之際停止 COVID-19 試驗

Fibrobiologics, Inc.盤中異動股價大漲5.25%

Nuvectis Pharma, Inc.盤中異動股價大跌5.13%報6.47美元

明晟公司MSCI北歐國家指數漲0.1%報340.56點。在10個板塊中北歐醫療保健板塊領跑。生物技術公司Genmab A

伯恩斯坦下調安進目標價至335美元

癌症早篩公司Grail（GRAL）更新2025年現金消耗指引至3.1億美元主要由於其Galleri檢測產品採用率提升及合

癌症早篩公司Grail更新2025年現金消耗指引

环球市场播报

BUZZ-伯恩斯坦以MariTide風險為由下調安進公司的交易預測值

美國OTC市場Syros Pharmaceuticals, Inc.盤中異動股價大漲45.45%報0.002美元

BUZZ-血癌細胞療法獲得早期數據後，免疫生物公司業績上升

Regenxbio Inc.盤中異動股價大漲5.06%報8.51美元

Immatics N.V.盤中異動大幅下跌11.84%報5.66美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4139/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4139","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4139\",,,,,undefined,":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":59.56654,"timestamp":1755115199999,"preClose":58.503128,"halted":0,"volume":958631278,"delay":0,"changeRate":0.018177,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":1.063412,"latestTime":"08-13 16:00:00 EDT","open":58.503036,"high":59.631737,"low":58.502995,"amount":15645134169.045805,"amplitude":0.019294,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1755178200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.968524,"peRate":-105.007267,"turnoverRate":0.031222,"increases":404,"decrements":127,"flats":8,"marketCap":1552786905282.5,"floatMarketCap":1387135833407.4668},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4139\",,,,,undefined,":{"symbol":"BK4139","high":59.631737,"amplitude":0.019294,"preClose":58.503128,"low":58.502995,"pbRate":"5.968524","latestPrice":59.56654,"volume":958631278,"delay":0,"open":58.503036,"prevYearClose":54.762566,"prevWeekClose":57.9806,"prevMonthClose":57.7408,"prevQuarterClose":55.2146,"fiveDayClose":57.6165,"twentyDayClose":57.6704,"sixtyDayClose":53.4543,"secType":"PLATE","market":"US","turnoverRate":0.031222,"peRate":-105.007267,"marketCap":1552786905282.5,"floatMarketCap":1387135833407.4668,"timestamp":1755115199999,"nameCN":"生物科技"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4139\",,,,undefined,":{"bkCode":"BK4139","up":404,"down":127,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4139\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559707958","title":"BSC Meme幣BTSR市值突破1800萬美元，日內漲超48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559707958","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559707958?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 16:54","pubTimestamp":1755161693,"startTime":"0","endTime":"0","summary":"<div class=\"line-clamp-4 text-custom-000000/70 dark:text-custom-FFFFFF/60 text-18 font-400 tracking-1 leading-40 whitespace-pre-line\"><p>Odaily星球日报讯 据 GMGN 行情数据，或受 WLFI 财库公司 ALT 5 Sigma 股价上涨影响。，BSC Meme 币 BTSR 市值短时上涨突破 1800 万美元，现报 1844 万美元，日内涨幅达 48%。</p><p>据悉，BSTR 是 BNB 链上管理 WLFI 等资产的 DAO。</p></div>","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/zh-CN/newsflash/443398","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BTSR","LU1878469433.USD","BK4139","ALT","BK4599","BK4134"],"gpt_icon":0},{"id":"2559958241","title":"百濟神州(06160)授出合共約3.44億股美國存托股份的受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2559958241","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559958241?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 16:53","pubTimestamp":1755161615,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)公布，于2025年8月8日，董事会薪酬委员会根据2016期权及激励计划的条款向375名承授人授出涉及合共34,361股美国存托股份的受限制股份单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","BK1583","BK1500","BK4585","BK4139","688235","LU1969619763.USD","06160","LU0588546209.SGD","BK0239","BK4526","LU0307460666.USD","BK1161","ONC","LU2328871848.SGD"],"gpt_icon":0},{"id":"2559930002","title":"ALT5 Sigma盤前上漲5.7%，暫報7.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559930002","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559930002?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 16:16","pubTimestamp":1755159387,"startTime":"0","endTime":"0","summary":"<div class=\"line-clamp-4 text-custom-000000/70 dark:text-custom-FFFFFF/60 text-18 font-400 tracking-1 leading-40 whitespace-pre-line\"><p>Odaily星球日报讯 行情显示，ALT 5 Sigma 盘前上涨 5.7%，暂报 7.34 美元。</p><p>此前消息，ALT 5 Sigma 宣布 15 亿美元融资以启动 World Liberty Financial 国库战略。</p></div>","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/zh-CN/newsflash/443389","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["ALT","BK4139","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"1146092287","title":"港股生物醫藥股延續強勢！榮昌生物漲超16%創近4年新高，晶泰控股漲超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146092287","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146092287?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 10:45","pubTimestamp":1755139542,"startTime":"0","endTime":"0","summary":"港股异动｜生物医药股延续强势，$荣昌生物(09995)$涨8%，$药明巨诺-B(02126)$、$亿胜生物科技(01061)$涨超7%，$同源康医药-B(02410)$涨超5%，$百济神州(06160)$涨近4%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","09995","BK1588","BK1500","ONC","HSTECH","HSCEI","01061","LU1064131003.USD","LU2148510915.USD","161726","BK1574","LU2328871848.SGD","399441","BK4614","LU1969619763.USD","YANG","07226","LU1064130708.USD","02126","BK1583","02410","LU2488822045.USD","BK0239","BK4526","BK1161","BK4139","BK4585","06160","BK1515","688331"],"gpt_icon":0},{"id":"2559935893","title":"港股異動 | 百濟神州(06160)漲超4% 皮下替雷利珠單抗啓動國內首個Ⅲ期臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2559935893","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559935893?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 10:28","pubTimestamp":1755138517,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州(06160)涨超4%，截至发稿，涨4.12%，报187.2港元，成交额3.41亿港元。消息面上，8月13日，药物临床试验登记与信息公示平台官网显示，百济神州启动了PD-1抑制剂替雷利珠单抗皮下注射的Ⅲ期临床，适应症为联合化疗作为局部晚期不可切除或转移性胃或胃食管结合部腺癌患者一线治疗。据悉，替雷利珠单是百济神州的核心产品，目前已在全球47个市场获批。自2019年上市至今，替雷利珠单抗已覆盖尿路上皮癌、非小细胞肺癌等重点癌种，惠及全球百万患者。2025上半年，替雷利珠单抗创造了26.43亿元的销售额 ，同比增长20.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329394.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4139","BK1588","BK4526","LU0588546209.SGD","LU2328871848.SGD","06160","BK4585","LU1969619763.USD","ONC","LU0307460666.USD","BK1583","688235","BK1161","BK1500"],"gpt_icon":0},{"id":"2559933118","title":"學者建議調整房產投資負扣税應用  聯邦政府表示暫無改變負扣税計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2559933118","media":"澳洲财经见闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559933118?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 09:48","pubTimestamp":1755136135,"startTime":"0","endTime":"0","summary":"最新分析显示，平均而言，与拥有多套房产的投资者相比，仅拥有一套投资房的投资者在每套房产上的损失更大。 RMIT大学可持续…","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/%e5%ad%a6%e8%80%85%e5%bb%ba%e8%ae%ae%e8%b0%83%e6%95%b4%e6%88%bf%e4%ba%a7%e6%8a%95%e8%b5%84%e8%b4%9f%e6%89%a3%e7%a8%8e%e5%ba%94%e7%94%a8-%e8%81%94%e9%82%a6%e6%94%bf%e5%ba%9c%e8%a1%a8%e7%a4%ba%e6%9a%82/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","BK4588","BK4585","ACTU","BK4139","LU2362541273.HKD","ATO","LU2362540622.SGD","BK4197"],"gpt_icon":0},{"id":"2559933225","title":"180 Life Sciences Corp.8月13日成交額為12.18億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559933225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559933225?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 09:20","pubTimestamp":1755134412,"startTime":"0","endTime":"0","summary":"美东时间2025年8月13日，180 Life Sciences Corp.成交额为12.18亿美元，成交额较昨日减少32.68%，当日成交量为8811.64万股。180 Life Sciences Corp.于2025年8月13日涨4.49%，报10.7美元，该股过去5个交易日涨198.88%，年初至今涨487.91%，过去60日涨806.78%。它有一个可报告的运营部门，即 iGaming。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250814092017a6e4dc3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250814092017a6e4dc3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNF"],"gpt_icon":1},{"id":"2559398717","title":"工會重磅提案：澳洲應推行四天工作制，應對“過勞危機”與工資停滯","url":"https://stock-news.laohu8.com/highlight/detail?id=2559398717","media":"澳洲财经见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559398717?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 07:48","pubTimestamp":1755128932,"startTime":"0","endTime":"0","summary":"据澳洲九号台新闻8月13日报道，澳洲工会理事会（ACTU）呼吁澳洲采用四天工作 制，应对澳人持续创纪录长时间工作的现状。…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/%e5%b7%a5%e4%bc%9a%e9%87%8d%e7%a3%85%e6%8f%90%e6%a1%88%ef%bc%9a%e6%be%b3%e6%b4%b2%e5%ba%94%e6%8e%a8%e8%a1%8c%e5%9b%9b%e5%a4%a9%e5%b7%a5%e4%bd%9c%e5%88%b6%ef%bc%8c%e5%ba%94%e5%af%b9%e8%bf%87/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","BK4139"],"gpt_icon":0},{"id":"2559984936","title":"美國命令 Vaxart 在 mRNA 終止之際停止 COVID-19 試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2559984936","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559984936?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 05:16","pubTimestamp":1755119762,"startTime":"0","endTime":"0","summary":"路透8月13日 - Vaxart VXRT.PK周三表示，它收到了停止其COVID-19中期试验筛选和注册工作的命令，加入了多家失去政府对其疫苗项目资助的生物技术公司的行列。该药物开发商说，它将通过监测已参加试验的人员，继续研究其口服 COVID-19 疫苗，但将停止新的注册工作。生物医学高级研究与发展局帮助公司开发医疗用品，以应对公共卫生威胁，并在 COVID 大流行期间为疫苗开发提供了数十亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4T3U51F1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","VXRT","BK4139"],"gpt_icon":0},{"id":"2559986796","title":"Fibrobiologics, Inc.盤中異動 股價大漲5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559986796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559986796?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 03:16","pubTimestamp":1755112581,"startTime":"0","endTime":"0","summary":"北京时间2025年08月14日03时16分，Fibrobiologics, Inc.股票出现波动，股价急速拉升5.25%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508140316219745f7b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508140316219745f7b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2559663958","title":"Nuvectis Pharma, Inc.盤中異動 股價大跌5.13%報6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559663958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559663958?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 00:43","pubTimestamp":1755103414,"startTime":"0","endTime":"0","summary":"北京时间2025年08月14日00时43分，Nuvectis Pharma, Inc.股票出现异动，股价急速下挫5.13%。截至发稿，该股报6.47美元/股，成交量5.5539万股，换手率0.22%，振幅6.00%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081400433494e18cd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081400433494e18cd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2559598801","title":"明晟公司MSCI北歐國家指數漲0.1%報340.56點。在10個板塊中北歐醫療保健板塊領跑。生物技術公司Genmab A","url":"https://stock-news.laohu8.com/highlight/detail?id=2559598801","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559598801?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 23:37","pubTimestamp":1755099475,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4112","LU2265009873.SGD","LU0109391861.USD","LU2095319765.USD","LU2210150020.SGD","GNMSF","LU0175139822.USD","LU0289739343.SGD","LU0289960550.SGD","LU0511384066.AUD","LU0320765059.SGD","LU0708995401.HKD","LU1267930730.SGD","BK4585","LU0672654240.SGD","LU0289961442.SGD","MSCI","BK4139","LU1804176565.USD","LU2210149790.SGD","BK4588","GMAB"],"gpt_icon":0},{"id":"2559398827","title":"伯恩斯坦下調安進目標價至335美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559398827","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559398827?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 23:25","pubTimestamp":1755098750,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2242652126.USD","LU0868494617.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4534","LU0320765992.SGD","LU1571399168.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4585","LU0889565916.HKD","BK4599","LU0122379950.USD","LU1061106388.HKD","LU0109394709.USD","BK4533","BK4566","LU2112291526.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU0058720904.USD","AMGN","IE00B2B36J28.USD","IE0009355771.USD","LU1023059063.AUD","LU2089984988.USD","BK4139","SG9999001440.SGD","LU2468319806.SGD","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4588","BK4581","LU1057294990.SGD"],"gpt_icon":0},{"id":"2559600794","title":"癌症早篩公司Grail（GRAL）更新2025年現金消耗指引至3.1億美元主要由於其Galleri檢測產品採用率提升及合","url":"https://stock-news.laohu8.com/highlight/detail?id=2559600794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559600794?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 22:30","pubTimestamp":1755095402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2559998664","title":"癌症早篩公司Grail更新2025年現金消耗指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2559998664","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559998664?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 22:29","pubTimestamp":1755095340,"startTime":"0","endTime":"0","summary":"癌症早筛公司Grail（GRAL）更新2025年现金消耗指引至3.1亿美元，主要由于其Galleri检测产品采用率提升及合作伙伴关系扩展。得益于检测订单增长，该公司报告净亏损同比改善93%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-08-13/doc-infkwfyp3810947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2559600214","title":"BUZZ-伯恩斯坦以MariTide風險為由下調安進公司的交易預測值","url":"https://stock-news.laohu8.com/highlight/detail?id=2559600214","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559600214?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 22:24","pubTimestamp":1755095040,"startTime":"0","endTime":"0","summary":"** 经纪公司称，新目标剂量和进入后期研究的剂量调整会带来额外风险** 经纪公司称，下调目标价反映出 \"对 MariTide 达到最佳目标产品形象的可能性信心不足\"。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4S3U5110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU0320765992.SGD","LU0058720904.USD","LU1571399168.USD","BK4533","IE00BFTCPJ56.SGD","LU0122379950.USD","BK4534","LU1983299246.USD","BK4139","LU2242646821.SGD","LU0109394709.USD","LU2112291526.USD","BK4588","IE00BJT1NW94.SGD","LU2089984988.USD","LU1023059063.AUD","IE0002141913.USD","LU1061106388.HKD","LU2468319806.SGD","LU0289739699.SGD","LU0868494617.USD","IE00B2B36J28.USD","BK4585","BK4581","LU2242652126.USD","SG9999001440.SGD","IE00B4R5TH58.HKD","BK4599","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4566","LU0889565916.HKD","AMGN"],"gpt_icon":0},{"id":"2559986418","title":"美國OTC市場Syros Pharmaceuticals, Inc.盤中異動 股價大漲45.45%報0.002美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559986418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559986418?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 22:16","pubTimestamp":1755094560,"startTime":"0","endTime":"0","summary":"北京时间2025年08月13日22时16分，美国OTC市场Syros Pharmaceuticals, Inc.股票出现波动，股价快速拉升45.45%。截至发稿，该股报0.002美元/股，成交量513股，换手率0.00%，振幅45.45%。美国OTC市场Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。美国OTC市场Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813221600a4868a2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813221600a4868a2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRS","SYRSW"],"gpt_icon":0},{"id":"2559760086","title":"BUZZ-血癌細胞療法獲得早期數據後，免疫生物公司業績上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2559760086","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559760086?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 21:48","pubTimestamp":1755092894,"startTime":"0","endTime":"0","summary":"BUZZ-血癌细胞疗法获得早期数据后，免疫生物公司业绩上升8月13日 - ** 生物技术公司ImmunityBio IBRX.O股价上涨4.5%，至2.58美元** 公司称其实验性细胞疗法在一项早期研究中帮助两名患者消除了一种血癌的所有症状** 这种名为CD19 CAR-NK的疗法正在开发中，用于治疗Waldenstrom巨球蛋白血症--一种影响白细胞的罕见、生长缓慢的癌症。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4S3U50YX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2559936894","title":"Regenxbio Inc.盤中異動 股價大漲5.06%報8.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559936894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559936894?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 21:42","pubTimestamp":1755092579,"startTime":"0","endTime":"0","summary":"北京时间2025年08月13日21时42分，Regenxbio Inc.股票出现波动，股价急速上涨5.06%。截至发稿，该股报8.51美元/股，成交量3.6595万股，换手率0.07%，振幅3.40%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813214259a4867c52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813214259a4867c52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4505","BK4563","BK4139"],"gpt_icon":0},{"id":"2559985879","title":"Immatics N.V.盤中異動 大幅下跌11.84%報5.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559985879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559985879?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 21:34","pubTimestamp":1755092042,"startTime":"0","endTime":"0","summary":"北京时间2025年08月13日21时34分，Immatics N.V.股票出现波动，股价急速跳水11.84%。截至发稿，该股报5.66美元/股，成交量7.8953万股，换手率0.06%，振幅9.74%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.44%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813213402a486789b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813213402a486789b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0}],"pageSize":20,"totalPage":85,"pageCount":1,"totalSize":1682,"code":"91000000","status":"200"}]}}